Education
About Us
Working with TipRanks
Follow Us
GeoVax Labs (GOVX)
NASDAQ:GOVX
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.88Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant advancements in the development and potential expedited approval of key vaccine candidates, along with increased industry interest and collaboration potential. However, financial challenges, including decreased revenue and increased net loss, present concerns. Overall, the positive development news is somewhat tempered by the financial performance.Company Guidance
Expedited Development Path for GEO-MVA
GeoVax received guidance from the European Medicines Agency to bypass Phase I and Phase II trials for GEO-MVA, proceeding directly to a Phase III immuno-bridging trial, potentially accelerating marketing authorization and revenue generation.
Increased Interest in Partnerships and Funding
The company is experiencing increased interest in partnerships and collaborations from industry players and nondilutive funding organizations, particularly for GEO-MVA and GEO-CM04S1.
Progress in Vaccine Manufacturing Process
GeoVax is advancing its MVA vaccine manufacturing process, which is expected to provide a significant advantage in the production of MVA-based vaccines.
Significant Interest in GEO-CM04S1
GEO-CM04S1 is gaining recognition as a needed vaccine for immunocompromised adults, with ongoing clinical trials and discussions for potential partnerships.
GOVX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GOVX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $0.47 | $0.45 | -4.26% |
Jul 28, 2025 | $0.74 | $0.75 | +1.35% |
May 01, 2025 | $0.99 | $1.01 | +2.02% |
Mar 27, 2025 | $1.27 | $1.11 | -12.60% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does GeoVax Labs (GOVX) report earnings?
GeoVax Labs (GOVX) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is GeoVax Labs (GOVX) earnings time?
GeoVax Labs (GOVX) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GOVX EPS forecast?
GOVX EPS forecast for the fiscal quarter 2025 (Q4) is -0.23.